Neurontin Class Action To Include Generics Buyers
A Philadelphia judge has ruled that Pfizer Inc. can be held liable for off-label marketing of generic versions of its blockbuster epilepsy drug Neurontin, allowing a class action including people who...To view the full article, register now.
Already a subscriber? Click here to view full article